Talyst to present at the MHA Business Summit
Talyst, a pharmacy automation provider, announced this week that it will be exhibiting at the 2015 Managed Health Care Associates Business Summit in Las Vegas from March 18 to 20. Read More »
Talyst, a pharmacy automation provider, announced this week that it will be exhibiting at the 2015 Managed Health Care Associates Business Summit in Las Vegas from March 18 to 20. Read More »
BioPlus Specialty Pharmacy on Thursday announced that its charitable “Pay It Forward” campaign will be continuing in 2015. Read More »
The National Safety Council released the results on Thursday of a public opinion poll that showed almost 70 percent of opioid prescription-painkiller users don't know that sharing the medications is a felony. In most states, sharing narcotic opioid painkillers, such as oxycodone or hydrocodone, is the legal equivalent to selling heroin and is punishable by up to seven years in prison. Read More »
An article posted on phRMA’s blog, Catalyst, shares five essential truths about prescription drug spending in the United States. Read More »
ACADIA Pharmaceuticals said on Wednesday that Uli Hacksell has retired as CEO and from the board of directors, and that Steve Davis -- executive vice president, chief financial officer and chief business officer -- has been appointed interim CEO. Read More »
Heritage Development Organization, an affiliate of Heritage Provider Network, and Fresenius Medical Care said on Thursday that they have agreed to develop physician networks, care coordination and population health management services in select markets nationwide. Read More »
North York General Hospital announced today that Edith Rolko, director of pharmacy and infection prevention and control, will present the findings of a quality study about the Intelliguard Kit and Tray Management System at the Canadian Society of Hospital Pharmacists Seminar on March 20. Read More »
The National Association of Specialty Pharmacy (NASP) made an announcement Thursday that discussed the appointment of Jayson S. Slotnik as a health policy advisor and Virginia Sweeter to consultant for their meetings and education program. Read More »
Keryx Biopharmaceuticals said on Tuesday that Greg Madison was appointed to the company´s board of directors. Madison joined Keryx in 2014 and serves as the company´s president and chief operating officer. He will transition into the role of CEO by the end of May. Read More »
Actavis, PLC, and Allergan said on Tuesday that during meetings of the companies' shareholders, all proposals related to Actavis' planned acquisition of Allergan were approved. The shareholder approvals fulfill certain conditions tied to the closing of the acquisition, which is expected to be final by the end of the first quarter or early in the second quarter of this year. Read More »
Data released on Monday in the 2014 Express Scripts Drug Trend Report showed that new hepatitis C therapies with high prices and loopholes for compounded medications increased U.S. drug spending by 13.1 percent. Read More »
Pharmaceutical group sees no benefit to SB 5857. Read More »
The National Association of Specialty Pharmacy (NASP) said on Tuesday that it has moved its headquarters to the Washington, D.C., area. The NASP headquarters are now located at 1765 Duke St, Alexandria Va. 22314, effective immediately. Read More »
Parata Systems, a pharmacy technology solutions provider, said on Tuesday that it has appointed Emilie Ray to the Parata Board of Directors. "We are delighted Emilie has joined the board of directors," Parata CEO Tom Rhoads said. Read More »
Integra´s most recent version of its business automation tool, Logix, allows pharmacies to remove repetitive and time consuming procedures. Read More »
The large retail pharmacy company Walgreens has purchased Lovelace Retail Pharmacy, according to an announcement March 9. Read More »
Custom-compounded therapies unregulated by FDA. Read More »
Alkermes PLC on Monday announces that it has entered into a definitive agreement to sell its manufacturing facility in Gainesville, Ga., the manufacturing and royalty revenue associated with products manufactured at the facility and global rights to Meloxicam IV/IM to Recro Pharma, Inc., a specialty pharmaceutical company. Read More »
Retailer will add more than 20,000 jobs in 2015. Read More »
The $2.3 billion transaction expected to be completed by second quarter. Read More »